PTSD – Vielight Inc https://www.vielight.com Advancing brain photobiomodulation technology. Tue, 30 Sep 2025 20:39:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.3 https://www.vielight.com/wp-content/uploads/2025/06/cropped-Vielight-Favicon-General-1-32x32.webp PTSD – Vielight Inc https://www.vielight.com 32 32 PTSD and Cognition Published Clinical Study: Transcranial-Intranasal Photobiomodulation | Vielight Neuro https://www.vielight.com/blog/exploring-a-new-frontier-in-first-responder-wellness-transcranial-intranasal-photobiomodulation/ Thu, 10 Apr 2025 03:53:58 +0000 https://www.vielight.com/?p=50208

Reference: Tate, J., Lindsey, A., Wilde, L. (2025). Photobiomodulation for Cognitive Function and Wellness in Firefighters: A Pilot Study. Photobiomodulation, Photomedicine, and Laser Surgery. DOI: 10.1177/15578550251362096


Why This Study Matters

Firefighters endure extreme stress, traumatic events, and irregular schedules that can lead to:

  • Poor sleep and chronic fatigue

  • Persistent pain

  • Mood dysregulation

  • PTSD symptoms

  • Cognitive decline

Traditional wellness strategies—counseling, fitness, therapy—help, but may not fully address the neurological impact of sustained stress.

Researchers at the University of Utah investigated a new, non-invasive approach: transcranial-intranasal photobiomodulation (itPBM) — delivering near-infrared light to the brain through the nose and scalp using the Vielight Neuro Gamma to promote cellular health, reduce inflammation, and support brain network function.


How the Study Worked

  • Participants: 16 active-duty male firefighters (ages 25–58, mean ~43)

  • Device: Vielight Neuro Alpha

    • Wavelength: 810 nm near-infrared light

    • Modulation: 10 Hz

    • Configuration: Four transcranial LED clusters targeting default mode network hubs + one intranasal LED targeting ventral prefrontal cortex

  • Schedule:

    • 20 minutes per session

    • 3–4 sessions per week

    • 8 weeks total (~25 sessions)

  • Measurements: Standardized tests for PTSD symptoms, pain interference, mood disturbance, fluid cognition, and reintegration readiness.


Results at a Glance

Outcome Measure Baseline Mean (SD) Post-Treatment Mean (SD) p-Value Effect Size (Cohen’s d)
PTSD Checklist (PCL-5) 28.9 (12.0) 17.4 (8.4) 0.003 1.08 (large)
PROMIS Pain Interference 57.0 (7.5) 51.8 (7.4) 0.018 0.72 (moderate)
NIH Toolbox Fluid Cognition 102.0 (12.0) 108.8 (11.5) 0.009 0.83 (large)
Mood Disturbance (POMS-TMD) 41.7 (8.2) 36.0 (7.0) 0.012 0.74 (moderate)
Reintegration Index 85.2 (8.0) 90.7 (6.7) 0.007 0.84 (large)

Compliance: Over 90% attendance rate
Adverse Effects: None reported


What This Means

The therapy led to statistically and clinically significant improvements in:

  • PTSD symptom severity

  • Daily life pain interference

  • Problem-solving, memory, and cognitive flexibility

  • Emotional stability

  • Readiness for social reintegration

The effect sizes were moderate to large, meaning these improvements are likely noticeable in real-world settings.


Why It’s Exciting

  • Safe & drug-free — no reported side effects

  • Time-efficient — 20 minutes per session

  • Portable & scalable — possible integration into fire stations, clinics, and wellness centers

While this was a small, uncontrolled pilot, it’s a strong signal that larger randomized controlled trials are warranted.


“If tPBM can improve resilience, cognition, and recovery in firefighters, its potential for other high-stress professions—like healthcare workers, police, and veterans—is enormous.”

The post PTSD and Cognition Published Clinical Study: Transcranial-Intranasal Photobiomodulation | Vielight Neuro appeared first on Vielight Inc.

]]>